For over 30 years, MedWorks Media has been bridging research and clinical practice as a psychiatric medical publisher.
This issue features breakthrough research on genetic predictors of treatment response, novel ADHD therapies, and mechanistic studies of mood stabilizers, alongside complex case studies examining CBD-induced mania, psychogenic disorders, and comorbid conditions in autism spectrum disorder.
Validated assessment tools for clinical research, pharmaceutical trials, and psychiatric practice. Our collection represents decades of rigorous validation trusted by leading research institutions worldwide.
The definitive clinical reference guide for evidence-based psychopharmacology. Authored by Stanford University experts, providing comprehensive dosing guidelines and monitoring protocols.
For over 30 years, MedWorks Media has earned the trust of healthcare professionals worldwide through rigorous editorial standards and prestigious academic partnerships. Our publications are indexed in the world’s most respected medical databases and backed by leading experts from Harvard, Stanford, Columbia, and other premier institutions.
Medical publisher specializing in peer-reviewed journals and clinical resources for healthcare professionals since 1994.
Psychopharmacology Bulletin (ISSN 2472-2448) is indexed in PubMed, SCOPUS, Science Citation Index, and other major medical databases.
© 2025 MedWorks Media Inc. | All Rights Reserved
